Renal Insufficiency, Chronic: all 3,224 studies

Page 11 of 33. Open to participants first (706), then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate the Prospective Payment SystemCompletedNCT01717989Results posted
• Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.CompletedNCT01711853Phase 1Results posted
• Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D InsufficiencyCompletedNCT01704079Phase 3Results posted
• A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)CompletedNCT01698775Phase 3Results posted
• A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on DialysisCompletedNCT01696279Phase 2Results posted
• Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin AlfaCompletedNCT01693029Phase 3Results posted
• A Primary-Secondary Care Partnership to Prevent Adverse Outcomes in Chronic Kidney DiseaseCompletedNCT01688141Not applicableResults posted
• Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell FormationCompletedNCT01671605Results posted
• Quality of Life and Depression in Dialysis PatientsCompletedNCT01668628Results posted
• Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)CompletedNCT01663103Phase 4Results posted
• Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney DiseaseCompletedNCT01652872Phase 3Results posted
• Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D InsufficiencyCompletedNCT01651000Phase 3Results posted
• Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease PatientsCompletedNCT01640184Not applicableResults posted
• Efficacy of Vitamin D2 to Treat Chronic Kidney Disease Mineral and Bone DisorderCompletedNCT01633853Phase 4Results posted
• Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney DiseaseCompletedNCT01630889Phase 2Results posted
• A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With EpoetinCompletedNCT01628120Phase 3Results posted
• A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinCompletedNCT01628107Phase 3Results posted
• A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)CompletedNCT01621178Phase 3Results posted
• 4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney DiseaseCompletedNCT01587924Phase 2Results posted
• 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing DialysisCompletedNCT01587898Phase 2Results posted
• HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD)CompletedNCT01576341Phase 3Results posted
• An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney DiseaseCompletedNCT01574326Phase 2Results posted
• Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.CompletedNCT01574157Not applicableResults posted
• Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased DonorCompletedNCT01567085Phase 2Results posted
• Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With OlmesartanCompletedNCT01552954Phase 4Results posted
• OxCKD1 -Empowering Healthy Lifestyle Choices in Chronic Kidney DiseaseCompletedNCT01552317Not applicableResults posted
• Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept StudyTerminatedNCT01537315Phase 2Results posted
• Vitamin D as a Modifier of Serum Hepcidin in Children With Chronic Kidney DiseaseCompletedNCT01532349Phase 2Results posted
• PA21 Phase II Clinical Study in Hemodialysis Patients With HyperphosphatemiaCompletedNCT01521494Phase 2Results posted
• A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or DialysisCompletedNCT01519947Phase 4Results posted
• A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant PatientsCompletedNCT01506947Phase 4Results posted
• Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic HemodialysisCompletedNCT01503021Phase 3Results posted
• Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild HyperkalemiaCompletedNCT01493024Phase 2Results posted
• Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on DialysisCompletedNCT01478971Phase 3Results posted
• A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinCompletedNCT01473420Phase 3Results posted
• A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinCompletedNCT01473407Phase 3Results posted
• Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on DialysisCompletedNCT01464931Phase 1Results posted
• A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis PatientsCompletedNCT01464190Phase 3Results posted
• Exercise Trial in Chronic Kidney DiseaseCompletedNCT01462097Not applicableResults posted
• Alkali Therapy in Chronic Kidney DiseaseCompletedNCT01452412Phase 2/3Results posted
• Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary HyperparathyroidismTerminatedNCT01439867Phase 2Results posted
• A Study of LY2623091 in Male and Females With Chronic Kidney DiseaseCompletedNCT01427972Phase 2Results posted
• Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis PatientsCompletedNCT01427907Phase 4Results posted
• An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) as Maintenance Treatment in Patients With Chronic Renal Anemia on HaemodialysisCompletedNCT01422824Results posted
• Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone DisorderCompletedNCT01414114Phase 2Results posted
• Safe Kidney Care Cohort StudyCompletedNCT01407367Results posted
• A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)CompletedNCT01407276Phase 1Results posted
• Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian FederationCompletedNCT01401478Results posted
• Beneficial Effect of Probiotics on Chronic Kidney DiseaseCompletedNCT01391468Phase 4Results posted
• Vitamin D and Arterial Function in Patients With Chronic Kidney DiseaseCompletedNCT01384539Phase 3Results posted
• A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or HemodialysisCompletedNCT01382212Phase 3Results posted
• 42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and AnemiaCompletedNCT01381094Phase 2Results posted
• A Retrospective Observational Study of Hemoglobin Levels in Patients With Renal Anemia Treated With Mircera (Methoxy Polyethylene Glycol-Epoetin Beta)CompletedNCT01379963Results posted
• Denosumab for Prevention of Osteoporosis in Renal Transplant RecipientsCompletedNCT01377467Phase 3Results posted
• Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)CompletedNCT01371747Phase 2Results posted
• Quality of Life in Greek Hemodialysis Patients Receiving Zemplar IntravenousCompletedNCT01368042Results posted
• Safety and Tolerability of Valsartan in Children 6 to 17 Years of AgeCompletedNCT01365481Phase 3Results posted
• Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney DiseaseCompletedNCT01350388Not applicableResults posted
• Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary HyperparathyroidismCompletedNCT01341782Phase 3Results posted
• Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients With Severe Kidney Disease Undergoing Myocardial Perfusion ImagingCompletedNCT01336140Phase 4Results posted
• A Study to Assess Pharmacokinetics (PK) of Preladenant in Participants With Chronic Renal Impairment (CRI) (P06512)CompletedNCT01323855Phase 1Results posted
• Measurement of Kidney Blood Flow and Oxygen Levels by MRICompletedNCT01318967Not applicableResults posted
• An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Chronic Kidney Disease Not On DialysisCompletedNCT01318512Results posted
• A Chronic Care Model Based Quality Improvement (QI) Program to Improve the Care of Patients With Chronic Kidney Disease (CKD)CompletedNCT01290614Phase 4Results posted
• Study to Evaluate Cinacalcet in Children With Chronic Kidney DiseaseCompletedNCT01290029Phase 1Results posted
• Effect of Remote Ischaemic Preconditioning on Renal Function in Patients Undergoing Living Donor Kidney TransplantationCompletedNCT01289548Not applicableResults posted
• Effects of Aliskiren in Elderly Hypertensive Chronic Kidney Disease (CKD) PatientsCompletedNCT01284114Phase 4Results posted
• Pediatric Chronic Kidney Disease Safety and EfficacyTerminatedNCT01277510Phase 3Results posted
• Pedometers to Assess and Increase Physical Activity Among Children With Chronic Kidney DiseaseCompletedNCT01270529Not applicableResults posted
• Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on DialysisCompletedNCT01265992Results posted
• Evaluation of CLP in Heart Failure Patients With Chronic Kidney DiseaseCompletedNCT01265524Phase 2Results posted
• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney DiseaseTerminatedNCT01264679Phase 3Results posted
• Effects of Ergocalciferol on Erythropoetin Stimulating Agent DoseTerminatedNCT01263028Not applicableResults posted
• Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary ProcedureCompletedNCT01252810Phase 2Results posted
• Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or ParentsCompletedNCT01245374Phase 4Results posted
• Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With AnemiaCompletedNCT01244763Phase 2Results posted
• Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium ClearanceCompletedNCT01237899Phase 1Results posted
• Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and AnemiaCompletedNCT01235936Phase 2Results posted
• Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on HemodialysisCompletedNCT01227616Phase 4Results posted
• Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)CompletedNCT01224782Results posted
• A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5DCompletedNCT01222884Phase 3Results posted
• Impact of Vitamin D Therapies on Chronic Kidney DiseaseCompletedNCT01222234Not applicableResults posted
• Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)CompletedNCT01219855Phase 2/3Results posted
• Exploring Life Experience and Lifestyle Intervention Program Among Patients With CKDCompletedNCT01194518Not applicableResults posted
• A Study of Methoxy Polyethylene Glycol-epoetin Beta (Mircera) in Participants With Chronic Kidney Disease (PRIMAVERA)CompletedNCT01194154Phase 2Results posted
• Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney DiseaseCompletedNCT01191762Phase 3Results posted
• Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) PatientsTerminatedNCT01173848Phase 3Results posted
• The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration RateCompletedNCT01163162Phase 4Results posted
• Calcium and Phosphorus Balance and Calcium Kinetics in Patients With Stage 3/4 Chronic Kidney DiseaseCompletedNCT01161407Not applicableResults posted
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney DiseaseTerminatedNCT01155388Phase 3Results posted
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney DiseaseTerminatedNCT01155375Phase 3Results posted
• Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical PracticeTerminatedNCT01134315Results posted
• Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney DiseaseCompletedNCT01130597Phase 2Results posted
• Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKDCompletedNCT01128179Phase 2Results posted
• Pilot Study of Velcade® in IgA NephropathyCompletedNCT01103778Phase 4Results posted
• Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related AnaemiaCompletedNCT01102413Phase 3Results posted
• Trial to Optimize Mineral Outcomes in Dialysis PatientsCompletedNCT01100723Phase 4Results posted
• RenalGuard System and Contrast MediaCompletedNCT01098032Phase 3Results posted
• Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoing HaemodialysisCompletedNCT01084538Results posted
• Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical PracticeCompletedNCT01083849Results posted

← Renal Insufficiency, Chronic overview